BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.12.24 Stock BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.12.24
Add to a list
To use this feature you must be a member
Log inSign up

BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.12.24 Share Price

Warrant

DE000VM7SE52

Market Closed - Deutsche Boerse AG 19:01:32 05/07/2024 BST
0.039 EUR -27.78% Intraday chart for BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.12.24
Current month+44.44%
1 month-18.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart NOVO NORDISK A/S
Chart BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.12.24

Latest news about NOVO NORDISK A/S

Thinking about trading options or stock in Tesla, Microsoft, Novo Nordisk, Intel, or Solaredge Technologies? PR
Thinking about buying stock in NKGen Biotech, Novo Nordisk, SoundHound AI, Safety Shot, or Energy Fuels? PR
Thinking about buying stock in Estrella Immunopharma, Novo Nordisk, C4 Therapeutics, Plug Power, or LQR House? PR
Thinking about buying stock in Transphorm Technology, Stronghold Digital Mining, Broadcom, Novo Nordisk, or Datadog? PR
More news

Quotes 5-day view

Date Price Change
05/07/24 0.039 -27.78%
04/07/24 0.054 -3.57%
03/07/24 0.056 +60.00%
02/07/24 0.035 +52.17%
01/07/24 0.023 -14.81%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 07:01 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VM7SE5
ISINDE000VM7SE52
Date issued 02/01/2024
Strike 88 $
Maturity 20/12/2024 (167 Days)
Parity 10 : 1
Emission price 0.49 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.58 €
Lowest since issue 0.023 €
Delta-0.03x
Omega 8.099
Premium38.65x
Gearing279.92x
Moneyness 0.6171
Difference Strike -54.37 $
Difference Strike %-61.78%
Spread 0.01 €
Spread %19.23%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant